We are live on ! Find out more

35 hedge funds and large institutions have $13.2M invested in Savara in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,555% more call options, than puts

Call options by funds: $1.13M | Put options by funds: $31K

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

12% more capital invested

Capital invested by funds: $11.8M → $13.2M (+$1.43M)

0% more funds holding

Funds holding: 3535 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
35
Holders Change
Holders Change %
0%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
10
Reduced
6
Closed
4
Calls
$1.13M
Puts
$31K
Net Calls
+$1.1M
Net Calls Change
-$226K

SVRA Hedge Fund Activity: Q3 2014 in Review

35 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Savara (SVRA) for Q3 2014, worth a combined $13.2M — up 12% from $11.8M a quarter earlier.

Fund positioning in SVRA was balanced in Q3 2014: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 6 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $1.8M. The largest seller was Iguana Healthcare Management, exiting entirely with an estimated $315K sold.

  • 35 institutional investors held Savara (SVRA) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $13.2M of Savara stock for Q3 2014, up 12% quarter-over-quarter.
  • 4 funds opened new Savara positions in Q3 2014 and 4 closed out, a net change of 0 holders.
  • The largest Savara buyer in Q3 2014 was Baker Bros. Advisors, an estimated $1.8M added.
  • The largest Savara seller in Q3 2014 was Iguana Healthcare Management, an estimated $315K sold.

Based on aggregated 13F filings for Q3 2014.